MHC-1 expressed by cancer cells binds with leukocyte immunoglobulins (LILRB1) on TAMs and inhibits phagocytosis, which leads to deprivation of immune surveillance; interestingly, disruption of MHC-1 or LILRB1 enhances the phagocytosis of cancer cells [95]. Here, LILRB1 is linked to cancer.